360° SearchNetwork Hot Spots Trends Time Series

John J Castellani

Type: Person

Name: John J Castellani

First reported May 14 2013 - Updated May 14 2013 - 2 reports

John Castellani, CEO of PhRMA, Appointed to Pharmacist Partners'® Advisory Board

The announcement was made today by Pharmacist Partners, The Clinical Knowledge Organization™ (CKO). As a CKO, Pharmacist Partners utilizes pharmacists to provide education and advocacy to healthcare practitioners on behalf of its pharmaceutical clients. ... [Published Staten Island Live - May 14 2013]

Entities: Pharmacist, John J Castellani, Advisory Board, David Perry

First reported May 10 2013 - Updated May 10 2013 - 1 reports

John Castellani of PhRMA Appointed to Pharmacist Partners’ Advisory Board

John Castellani, President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), has been appointed to the advisory board of Pharmacist Partners, LLC. The announcement was made by Pharmacist Partners, the Clinical ... [Published Pharma-Mag - May 10 2013]

Entities: Pharmacist, John J Castellani, Advisory Board, Health Care, Appointed

First reported May 04 2013 - Updated May 04 2013 - 1 reports

Cost of Cancer Drugs

To the Editor: (editorial, May 2) minimizes the value of cancer medicines to patients and doesnt mention the realities of the reimbursement system and drug discovery process.Since 1980, life expectancy for cancer patients has increased by about three ... [Published New York Times - May 04 2013]

Entities: Cancer, Patient, Drugs, John J Castellani

First reported May 03 2013 - Updated May 03 2013 - 1 reports

PhRMA Wants Medication Adherence Coalition To Address Communication Restrictions

At the Council for Affordable Health Coverage’s event to launch its Prescription for Healthy America campaign, PhRMA President and CEO John Castellani says opening up the ability of drug manufacturers to communicate about their products could help improve ... [Published The Rose Sheet - May 03 2013]

Entities: Coalition, John J Castellani, Drugs

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Under Obamacare Program, Doctor Visits Would Become Data Points

A new nonprofit is putting millions of Obamacare dollars towards an effort to turn routine doctor visits into a treasure trove of data on what medical treatments work best.The Affordable Care Act created the Patient Centered Research Outcomes Institute ... [Published Oncology Business Review - Apr 25 2013]

Entities: Patient, Obamacare, treatments

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Under Obamacare program, doctor visits would become data points

A new nonprofit is putting millions of Obamacare dollars towards an effort to turn routine doctor visits into a treasure trove of data on what medical treatments work best. The Affordable Care Act created the Patient Centered Research Outcomes ... [Published Ezra Klein - Apr 23 2013]

Entities: Obamacare, treatments, John J Castellani, Patient, Health Care

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

AmerisourceBergen Corp

Four senators push bill to improve medicine tracking in pharmaceutical supply chain

It might shock many patients that this doesn't already exist, but four U.S. senators are pushing a bill that would eventually require every pill bottle be to traceable through each step of the pharmaceutical supply chain.email It might shock many patients ... [Published Philly.com - Apr 22 2013]

Entities: Supply Chain, Drugs, AmerisourceBergen Corp, Michael Bennet, Patient

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Is LaMattina pitching for Castellani's job?

An Open Letter To The PhRMA CEO On Pharma's ImageI, like many others, am very concerned about the poor image of the pharmaceutical industry. This open letter to PhRMA CEO, Mr. John Castellani, expresses these concerns and offers suggestions on how to ... [Published PharmaGossip - Apr 22 2013]

Entities: Clinical trials, Ben Goldacre, Drugs

First reported Apr 21 2013 - Updated Apr 21 2013 - 1 reports

Fixing Pharma's Reputation: IMHO, the Train Has Left the Station

In an "open letter" to PhRMA CEO, John Castellani, Forbes Blogger and former president of Pfizer Global Research, John LaMattina, offers several suggestions for improving the reputation of the pharmaceutical industry. You can read the "letter" here ... [Published Pharma Marketing Blog - Apr 21 2013]

Entities: John LaMattina, Research & Development, Clinical trials, Roche Holding AG, Pfizer Inc

First reported Apr 19 2013 - Updated Apr 20 2013 - 4 reports

LePage, medical and economic officials tout benefits of clinical trials [Bangor Daily News, Maine]

April 20AUGUSTA, Maine Gov. Paul LePage joined with medical and business leaders Friday at the State House to tout not only the public health benefits of clinical trials, but their economic effect on the state as well.The press event centered around the ... [Published Pharmacy Choice - Apr 20 2013]

Entities: Clinical trials, John J Castellani, Harold Alfond, Cancer, Cardiovascular Institute of Northwest Florida

First reported Apr 20 2013 - Updated Apr 20 2013 - 1 reports

An Open Letter To The PhRMA CEO On Pharma's Image

I, like many others, am very concerned about the poor image of the pharmaceutical industry. This open letter to PhRMA CEO, Mr. John Castellani, expresses these concerns and offers suggestions on how to improve things. Hereâs what I have to express:Dear ... [Published Forbes.com - Apr 20 2013]

Entities: Clinical trials, Ben Goldacre, Drugs, John J Castellani

First reported Apr 12 2013 - Updated Apr 12 2013 - 1 reports

US biopharma companies remain committed to research, in spite of challenges

John CastellaniInvestment in research and development by members of the (PhRMA) remained strong at an estimated US$48.5bn in 2012, slightly down from $48.6bn in 2011, in spite of economic, scientific, and business challenges. These efforts are highlighted ... [Published Manufacturing Chemist - Apr 12 2013]

Entities: Research & Development, John J Castellani, treatments, Venture Capital, Alzheimer's Disease

Quotes

...care delivery chain, including pharmacists, prescribers and biopharmaceutical research companies," said PhRMA President and CEO John J Castellani. "a growing body of evidence demonstrates that improving adherence to prescribed medicines and therapies leads to better health outcomes and helps to reduce costs in other areas of health care, such as hospitalization and surgery."

John Castellani, CEO of PhRMA, Appointed to Pharmacist Partners'® Advisory Board [Published Staten Island Live - May 14 2013]

"we all share the common goal of providing patients with the highest quality of care, and that goal drives this effort" commented John Castellani, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA)...

New coalition makes medication adherence its mission [Published Chain Drug Review - May 02 2013]

...goal of providing patients with the highest quality of care, and that goal drives this effort," said John J Castellani, President and CEO of PhRMA. "as we focus on advancing research and new medicines, our industry will continue to highlight solutions such as improved medication adherence that help strengthen better health outcomes and control health care costs."

New Initiative to Improve Medication Adherence Unveiled By Health Care, Consumer, Patient and Ind ... [Published Business Wire - May 02 2013]

More Content

sort by: Date \| Relevance
The Personalized Medicine Coalition's Ninth Ann... [Published Reuters - May 17 2013]
John Castellani, CEO of PhRMA, Appointed to Pha... [Published Staten Island Live - May 14 2013]
John Castellani, CEO of PhRMA, Appointed to Pha... [Published NewsBlaze - May 14 2013]
John Castellani, CEO of PhRMA, Appointed to Pha... [Published PR Newswire: Health - May 14 2013]
John Castellani of PhRMA Appointed to Pharmacis... [Published Pharma-Mag - May 10 2013]
FDA: From Risk Aversion to Approval Activism [Published Pharmaceutical Executive - May 07 2013]
Cost of Cancer Drugs [Published New York Times - May 04 2013]
PhRMA Wants Medication Adherence Coalition To A... [Published The Rose Sheet - May 03 2013]
New coalition makes medication adherence its mi... [Published Chain Drug Review - May 02 2013]
New Initiative to Improve Medication Adherence ... [Published TeleTrader.com - May 02 2013]
New Initiative to Improve Medication Adherence ... [Published Business Wire - May 02 2013]
PCORI Launches Clinical Research Network to Sup... [Published Applied Clinical Trials - Apr 30 2013]
Under Obamacare Program, Doctor Visits Would Be... [Published Oncology Business Review - Apr 25 2013]
Under Obamacare program, doctor visits would be... [Published Ezra Klein - Apr 23 2013]
Orexigen Therapeutics, Inc. (OREX) CEO Michael ... [Published BioSpace - Apr 22 2013]
Four senators push bill to improve medicine tra... [Published Philly.com - Apr 22 2013]
Orexigen CEO Michael Narachi Elected to PhRMA B... [Published Sys-Con Belgium - Apr 22 2013]
Is LaMattina pitching for Castellani's job? [Published PharmaGossip - Apr 22 2013]
Fixing Pharma's Reputation: IMHO, the Train Has... [Published Pharma Marketing Blog - Apr 21 2013]
LePage, medical and economic officials tout ben... [Published Pharmacy Choice - Apr 20 2013]
An Open Letter To The PhRMA CEO On Pharma's Image [Published Forbes.com - Apr 20 2013]
LePage, medical and economic officials tout ben... [Published Individual.com - Apr 20 2013]
Drug trials help Maine economy, new report says [Published Waterville Morning Sentinel - Apr 20 2013]
Maine clinical drug trials called lifesavers [Published Connecticut Post - Apr 19 2013]
PhRMA On Translating Science Into Hope [Published Life Science Leader - Apr 17 2013]
PhRMA Board Names Celgene's Robert J. Hugin as ... [Published PredictWallStreet - Apr 17 2013]
America’s Biopharma Industry Shows Continued Co... [Published eyeforpharma.com - Apr 15 2013]
Celgene Corporation's Becomes PhRMA Board Chair... [Published BioSpace - Apr 12 2013]
Celgene Corporation (CELG)'s Robert J. Hugin Be... [Published BioSpace - Apr 12 2013]
Celgene's Robert J. Hugin Becomes PhRMA Board C... [Published FinanzNachrichten.de - Apr 12 2013]

Blogs

sort by: Date \| Relevance
John Castellani of PhRMA Appointed to Pharmacis... [Published Pharma-Mag - May 10 2013] John Castellani, President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), has been appointed to the advisory board of Pharmacist Partners, LLC. The announcement was made by Pharmacist Partners, the Clinical ...
Under Obamacare program, doctor visits would be... [Published Ezra Klein - Apr 23 2013] A new nonprofit is putting millions of Obamacare dollars towards an effort to turn routine doctor visits into a treasure trove of data on what medical treatments work best. The Affordable Care Act created the Patient Centered Research Outcomes ...
Is LaMattina pitching for Castellani's job? [Published PharmaGossip - Apr 22 2013] An Open Letter To The PhRMA CEO On Pharma's ImageI, like many others, am very concerned about the poor image of the pharmaceutical industry. This open letter to PhRMA CEO, Mr. John Castellani, expresses these concerns and offers suggestions on how to ...
Fixing Pharma's Reputation: IMHO, the Train Has... [Published Pharma Marketing Blog - Apr 21 2013] In an "open letter" to PhRMA CEO, John Castellani, Forbes Blogger and former president of Pfizer Global Research, John LaMattina, offers several suggestions for improving the reputation of the pharmaceutical industry. You can read the "letter" here ...

Press Releases

sort by: Date \| Relevance
John Castellani, CEO of PhRMA, Appointed to Pha... [Published PR Newswire: Health - May 14 2013]
New Initiative to Improve Medication Adherence ... [Published Business Wire - May 02 2013]